搜索临床试验以:Metastatic breast Cancer, Palbociclib, Pharmacogenomic
总计28106个结果
-
National Cancer Institute (NCI)完全的
-
National Institutes of Health Clinical Center (CC)完全的
-
National Heart, Lung, and Blood Institute (NHLBI)完全的紫癜,血小板减少性,特发性 | 免疫性血小板减少性紫癜美国
-
Pfizer完全的
-
National Institute of Nursing Research (NINR)完全的
-
Hellenic Oncology Research GroupUniversity Hospital of Crete完全的
-
Christiana Care Health ServicesUniversity of Delaware完全的
-
Aptose Biosciences Inc.University of Chicago; Wake Forest University完全的
-
The Netherlands Cancer InstituteDutch Cancer Society未知因治疗引起的主诉的乳腺癌患者的更年期症状
-
Maxygen Holdings Ltd.Parexel; Maxygen ApS; Maxygen, Inc.未知
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's Hospital完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; United States Department... 和其他合作者完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and... 和其他合作者完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's Hospital完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital 和其他合作者完全的
-
Aga Khan University完全的
-
National Center for Complementary and Integrative...University of Missouri-Columbia完全的
-
University of WashingtonAventis Pharmaceuticals完全的
-
Eli Lilly and Company完全的乳腺癌巴西, 希腊, 匈牙利, 秘鲁, 波兰, 西班牙, 委内瑞拉
-
Institute of Child Health完全的
-
Tumor Center Regensburg完全的
-
Mast Therapeutics, Inc.University of California, San Diego完全的
-
Mast Therapeutics, Inc.未知
-
University Health Network, TorontoUnited States Department of Defense完全的